GlassScriptPhysician profile
Christine A King
NPI 1629380746
$18,178.36
in general payments reported to CMS, 2019-2025
17 companies · $2,540 in 2025
The $2,540 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,193 · 2022: $3,039 · 2023: $3,010 · 2024: $5,397 · 2025: $2,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,146 · Travel and Lodging: $1,802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,145.56 |
| Travel and Lodging | $1,801.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,324.95 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $4,482.13 | 2021-2025 | Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor, Versacross Access Solution |
| Abbott Laboratories | $3,932.57 | 2021-2025 | Amplatzer Amulet, Assurity, Confirm Rx |
| Biotronik INC. | $2,329.49 | 2021-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Rivacor 7 Dr-T |
| Impulse Dynamics (USA) INC. | $220.02 | 2021-2022 | |
| Biosense Webster, INC. | $193.49 | 2021-2025 | Nuvision Ice Catheter |
| Cordis US Corp. | $163.99 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Janssen Pharmaceuticals, INC | $105.17 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.52 | 2023-2025 | Jardiance |
| Cardiva Medical, INC. | $83.44 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $47.74 | 2022-2023 | Repatha |
| Shockwave Medical, INC | $46.80 | 2022 | |
| Pfizer INC. | $44.32 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.67 | 2023-2024 | Lifevest |
| Agios Pharmaceuticals, INC. | $28.65 | 2023 | Pyrukynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28.17 | 2024 | |
| Merck Sharp & Dohme LLC | $13.24 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.